1.1.................... moves to amend the ....... amendment (S2470DE2) to S.F. No. 2470,
1.2the first unofficial engrossment, as follows:
1.3Page 2, line 15, delete "mentally" and insert "developmentally" and delete "the
1.4patient is"
1.5Page 2, line 16, after "medication" insert a comma
1.6Page 3, line 9, delete "smoke" and insert "vapor"
1.7Page 3, line 18, delete "federally approved" and insert "federally-approved"
1.8Page 3, line 19, after "cannabis" insert a comma
1.9Page 3, line 21, delete "and provide"
1.10Page 3, line 22, delete "regulations for"
1.11Page 3, line 24, after the period, insert "The commissioner shall require any
1.12manufacturer application for registration to pay a fee of $20,000. If a manufacturer is not
1.13selected for registration, the commissioner shall refund $19,000 to that manufacturer."
1.14Page 4, line 19, delete "website" and insert "Web site"
1.15Page 4, line 20, delete "complete rulemaking for any" and insert "adopt"
1.16Page 4, line 22, after "2015" insert a comma and after "notice" insert "of proposed
1.17rules"
1.18Page 4, line 29, delete the first "may" and insert "shall" and delete "twice" and
1.19insert "three times"
1.20Page 4, line 30, delete "may" and insert "shall"
1.21Page 5, line 1, after "qualifying" insert "medical"
1.22Page 5, line 5, after "health" insert "care"
1.23Page 6, line 3, after "practitioner" insert "that is dated"
1.24Page 6, line 12, delete "mentally" and insert "developmentally"
1.25Page 6, line 15, after "require" insert "the person"
1.26Page 6, line 16, delete "the person"
1.27Page 6, line 17, delete "the person"
2.1Page 6, line 19, delete "the person"
2.2Page 7, line 23, delete "(l)" and insert "(m)"
2.3Page 7, line 31, after "in" insert "this" and delete "152.22"
2.4Page 8, line 5, delete the first "and" and delete the first comma
2.5Page 8, line 6, delete "mentally" and insert "developmentally"
2.6Page 9, line 7, delete "meet" and insert "meets"
2.7Page 9, line 11, delete everything after "any"
2.8Page 9, line 12, delete everything before "be" and insert "employees licensed as a
2.9pharmacist pursuant to chapter 151 and the rules promulgated pursuant to that chapter"
2.10Page 9, line 22, delete "patient" and insert "registry" and delete "2, paragraph (d)"
2.11and insert "subdivision 2d"
2.12Page 9, line 24, delete everything after "manufacturer"
2.13Page 9, line 25, delete everything before "has" and insert "licensed by a pharmacist
2.14pursuant to chapter 151 and the rules promulgated pursuant to that chapter"
2.15Page 10, line 9, delete "2, paragraph (d)" and insert "2d"
2.16Page 10, line 13, after "dosages" insert "of medical cannabis products"
2.17Page 10, line 20, delete the semicolon and insert a period
2.18Page 11, line 20, delete "resident" and insert "residence"
2.19Page 11, line 36, after "section" insert a period
2.20Page 12, line 27, after "Fees" insert "; medical cannabis registry account"
2.21Page 12, line 32, after "the" insert "medical cannabis registry account in the"
2.22Page 12, line 34, after the period, insert "The manufacturer may charge fees
2.23associated with the delivery of medical cannabis pursuant to subdivision 8, paragraph (i),
2.24but shall only charge the fee to those patients who received the delivery service."
2.25Page 12, line 36, after "fees" insert a period
2.26Page 13, line 3, delete "inpatient"
2.27Page 14, delete section 3 and insert:

2.28    "Sec. 3. [152.23] MEDICAL CANNABIS MANUFACTURER ACCOUNT.
2.29    Subdivision 1. Creation of account. (a) A medical cannabis manufacturer account
2.30is created in the state government special revenue fund for the purpose of carrying out
2.31the commissioner's responsibilities associated with the regulation of medical cannabis
2.32manufacturers under section 152.22.
2.33    (b) The account shall be kept in the state treasury and shall be paid out in the manner
2.34prescribed by law.
3.1    (c) The account shall consist of the money paid by the medical cannabis
3.2manufacturer as provided in this section. Money in the account is appropriated to the
3.3commissioner of the health for the purposes of this section.
3.4    Subd. 2. Medical cannabis manufacturer; fees and expenses. When the
3.5commissioner of health audits, inspects, examines, or visits a medical cannabis
3.6manufacturer, the manufacturer of medical cannabis shall pay into the medical cannabis
3.7manufacturer account the per diem salaries and necessary expenses of the employees of the
3.8Department of Health who are conducting or participating in the examination, inspection,
3.9visit, or desk audit. The per diem salary fee shall be determined by the commissioner.
3.10    Subd. 3. Purposes for which the account may be spent. The commissioner shall
3.11use the fund for the payment of per diem salaries and expenses of special examiners and
3.12appraisers, the expenses of the commissioner of health or designee, and employees of
3.13the department when actively participating in any visit, audit, inspection, examination
3.14of the medical cannabis manufacturer. Expenses include meals, lodging, transportation,
3.15and mileage."
3.16Page 14, delete section 4 and insert:

3.17    "Sec. 4. [152.24] IMPACT ASSESSMENT OF MEDICAL CANNABIS
3.18THERAPEUTIC RESEARCH.
3.19    Subdivision 1. Task force on medical cannabis therapeutic research. (a) A
3.2023-member task force on medical cannabis therapeutic research is created to conduct an
3.21impact assessment of medical cannabis therapeutic research. The task force shall consist
3.22of the following members:
3.23    (1) two members of the house of representatives of the state of Minnesota, one
3.24selected by the speaker of the house, the other selected by the minority leader;
3.25    (2) two members of the senate of the state of Minnesota, one selected by the majority
3.26leader, the other selected by the minority leader;
3.27    (3) four members representing consumers or patients enrolled in the registry
3.28program, including at least two parents of patients under age 18;
3.29    (4) four members representing health care providers, including one licensed
3.30pharmacist;
3.31    (5) four members representing law enforcement, one from the Minnesota Chief of
3.32Police Association, one from the Minnesota Sheriff's Association, one from the Minnesota
3.33Police and Peace Officers Association, and one from the Minnesota County Attorneys
3.34Association;
3.35    (6) four members representing substance use disorder treatment providers; and
3.36    (7) the commissioners of health, human services, and public safety.
4.1    (b) Task force members listed under paragraph (a), clauses (3), (4), (5), and (6), shall
4.2be appointed by the governor. Members shall serve on the task force at the pleasure of
4.3the appointing authority.
4.4    (c) There shall be two co-chairs of the task force chosen from the members listed
4.5under paragraph (a). One co-chair shall be selected by the speaker of the house and
4.6the other co-chair shall be selected by the majority leader of the senate. The expense
4.7reimbursement for members of the task force is governed by section 15.059.
4.8    (d) Members of the task force other than those in paragraph (a), clauses (1), (2), and
4.9(7), shall receive expenses as provided in section 15.059, subdivision 6.
4.10    Subd. 2. Impact assessment. The task force shall hold hearings to conduct
4.11an assessment that evaluates the impact of the use of medical cannabis and evaluate
4.12Minnesota's activities and other states' activities involving medical cannabis, and offer
4.13analysis of:
4.14    (1) program design and implementation;
4.15    (2) the impact on the health care provider community;
4.16    (3) patient experiences;
4.17    (4) the impact on the incidence of substance abuse;
4.18    (5) access to and quality of medical products;
4.19    (6) the impact on law enforcement and prosecutions;
4.20    (7) public awareness and perception; and
4.21    (8) any unintended consequences.
4.22    Subd. 3. Reports to the legislature. (a) The co-chairs shall submit the following
4.23reports to the chairs and ranking minority members of the legislative committees and
4.24divisions with jurisdiction over health and human services, public safety, judiciary, and
4.25civil law:
4.26    (1) by February 1, 2015, a report on the design and implementation of the registry
4.27program; and
4.28    (2) every two years thereafter, a complete report on the impact assessment.
4.29    (b) The task force may make recommendations to the legislature on whether to add
4.30or remove conditions from the list of qualifying medical conditions.
4.31    Subd. 4. Expiration. The task force on medical cannabis therapeutic research
4.32does not expire."
4.33Page 16, delete section 5 and insert:

4.34    "Sec. 5. APPROPRIATIONS, MEDICAL CANNABIS RESEARCH.
4.35    Subdivision 1. Health Department. $2,795,000 is appropriated in fiscal year
4.362015 from the general fund to the commissioner of health for implementing the medical
5.1cannabis therapeutic research study in this act. The base for this appropriation is $829,000
5.2in fiscal year 2016 and $728,000 in fiscal year 2017.
5.3    Subd. 2. Legislative Coordinating Commission. $21,000 is appropriated in
5.4fiscal year 2015 from the general fund to the Legislative Coordinating Commission to
5.5administer the task force on medical cannabis therapeutic research and for the task force to
5.6conduct the impact assessment on the use of cannabis for medicinal purposes.
5.7    Subd. 3. Health Department base. The base appropriation for the commissioner
5.8of health from the state government special revenue fund is increased by $631,000 in
5.9fiscal year 2016 and fiscal year 2017 for costs associated with operations of the medical
5.10cannabis manufacturers under Minnesota Statutes, section 152.22, subdivision 13."